FDA NDC Directory · JSON-LD · Markdown

Doxorubicin Hydrochloride

NDC 68001-493 · HUMAN PRESCRIPTION DRUG · INJECTABLE, LIPOSOMAL

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA203263
Dosage form / routeINJECTABLE, LIPOSOMAL · INTRAVENOUS
Active ingredientsDOXORUBICIN HYDROCHLORIDE (2 mg/mL)
Marketing started20210531
Package count1

External sources

Source: openFDA. Public-domain (CC0).